tiprankstipranks
Trending News
More News >
Windlas Biotech Ltd. (IN:WINDLAS)
:WINDLAS
India Market

Windlas Biotech Ltd. (WINDLAS) Financial Statements

Compare
0 Followers

Windlas Biotech Ltd. Financial Overview

Windlas Biotech Ltd.'s market cap is currently ₹17.91B. The company's EPS TTM is ₹8.48; its P/E ratio is 26.37; and it has a dividend yield of 0.71%. Windlas Biotech Ltd. is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 7.60B₹ 6.29B₹ 5.11B₹ 4.63B₹ 4.27B
Gross Profit₹ 2.88B₹ 2.28B₹ 1.81B₹ 1.61B₹ 1.52B
Operating Income₹ 661.22M₹ 652.21M₹ 479.24M₹ 402.76M₹ 434.14M
EBITDA₹ 1.12B₹ 916.40M₹ 701.91M₹ 591.29M₹ 361.68M
Net Income₹ 609.94M₹ 581.87M₹ 426.26M₹ 380.89M₹ 158.32M
Balance Sheet
Cash & Short-Term Investments₹ 2.40B₹ 2.04B₹ 1.32B₹ 1.76B₹ 542.55M
Total Assets₹ 7.60B₹ 6.26B₹ 5.29B₹ 4.91B₹ 2.96B
Total Debt₹ 325.97M₹ 36.41M₹ 49.93M₹ 66.37M₹ 323.49M
Net Debt₹ 321.73M₹ -16.47M₹ 13.07M₹ 60.67M₹ 164.19M
Total Liabilities₹ 2.55B₹ 1.76B₹ 1.27B₹ 962.33M₹ 970.04M
Stockholders' Equity₹ 5.06B₹ 4.50B₹ 4.02B₹ 3.95B₹ 1.99B
Cash Flow
Free Cash Flow₹ 159.93M₹ 712.76M₹ -99.25M₹ -56.74M₹ 56.07M
Operating Cash Flow₹ 681.87M₹ 1.09B₹ 609.65M₹ 91.30M₹ 114.54M
Investing Cash Flow₹ -740.64M₹ -920.68M₹ -141.10M₹ -1.55B₹ -201.98M
Financing Cash Flow₹ 10.13M₹ -152.90M₹ -437.39M₹ 1.30B₹ 7.76M
Currency in INR

Windlas Biotech Ltd. Earnings and Revenue History

Windlas Biotech Ltd. Debt to Assets

Windlas Biotech Ltd. Cash Flow

Windlas Biotech Ltd. Forecast EPS vs Actual EPS